K. E. Walker

495 total citations
19 papers, 397 citations indexed

About

K. E. Walker is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, K. E. Walker has authored 19 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in K. E. Walker's work include Synthesis and bioactivity of alkaloids (12 papers), Synthesis and Biological Evaluation (10 papers) and Synthesis and pharmacology of benzodiazepine derivatives (3 papers). K. E. Walker is often cited by papers focused on Synthesis and bioactivity of alkaloids (12 papers), Synthesis and Biological Evaluation (10 papers) and Synthesis and pharmacology of benzodiazepine derivatives (3 papers). K. E. Walker collaborates with scholars based in United States, Finland and United Kingdom. K. E. Walker's co-authors include William M. McIsaac, Beng T. Ho, Kyriakos Charalampous, Dorothy Taylor, B. T. HO, Patricia M. Kralik, Antonio Orengo, Leo F. Englert, M.M. Airaksinen and Daniel Taylor and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and British Journal of Cancer.

In The Last Decade

K. E. Walker

17 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. E. Walker United States 13 234 200 102 62 48 19 397
Talmage R. Bosin United States 13 237 1.0× 178 0.9× 98 1.0× 56 0.9× 76 1.6× 52 491
H. Bruderer Switzerland 14 220 0.9× 255 1.3× 230 2.3× 95 1.5× 57 1.2× 21 685
Norihiko Tanno Japan 13 225 1.0× 253 1.3× 147 1.4× 103 1.7× 41 0.9× 20 715
Asher Kalir Israel 17 362 1.5× 270 1.4× 256 2.5× 104 1.7× 61 1.3× 52 778
Joseph T. Strupczewski United States 10 170 0.7× 142 0.7× 131 1.3× 50 0.8× 58 1.2× 14 466
Maurice W. Gittos France 9 196 0.8× 112 0.6× 168 1.6× 59 1.0× 35 0.7× 21 445
Robert J. Borgman United States 11 89 0.4× 97 0.5× 93 0.9× 47 0.8× 19 0.4× 18 320
Philip Abraham United States 12 315 1.3× 164 0.8× 311 3.0× 32 0.5× 59 1.2× 22 643
David B. Rusterholz United States 11 172 0.7× 129 0.6× 135 1.3× 20 0.3× 62 1.3× 18 371
Edward Macko United Kingdom 12 167 0.7× 397 2.0× 92 0.9× 134 2.2× 18 0.4× 34 692

Countries citing papers authored by K. E. Walker

Since Specialization
Citations

This map shows the geographic impact of K. E. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. E. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. E. Walker more than expected).

Fields of papers citing papers by K. E. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. E. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. E. Walker. The network helps show where K. E. Walker may publish in the future.

Co-authorship network of co-authors of K. E. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of K. E. Walker. A scholar is included among the top collaborators of K. E. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. E. Walker. K. E. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Spender, Lindsay C., Mark Baxter, K. E. Walker, et al.. (2025). AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma. British Journal of Cancer. 133(5). 709–722.
2.
Airaksinen, M.M., et al.. (1978). The Uptake of 6‐Methoxy‐1,2,3,4‐Tetrahydro‐β‐carboline and its Effect on 5‐Hydroxytryptamine Uptake and Release in Blood Platelets. Acta Pharmacologica et Toxicologica. 43(5). 375–380. 20 indexed citations
3.
Ho, Beng T., et al.. (1974). Effects of Aromatic Aldehydes on O-Methylation of Dopamine and Norepinephrine in in Vitro. Journal of Pharmaceutical Sciences. 63(8). 1261–1264. 3 indexed citations
4.
Ho, Beng T., et al.. (1973). Inhibition of MAO by β-Carbolinium Halides. Journal of Pharmaceutical Sciences. 62(1). 36–39. 13 indexed citations
5.
HO, B. T., S.F. Pong, Ronald G. Browne, & K. E. Walker. (1973). Acetylation of mescaline in rat brains. Cellular and Molecular Life Sciences. 29(3). 275–277. 1 indexed citations
6.
Ho, Beng T., et al.. (1973). A new peripheral monoamine oxidase inhibitor: 2,9-dimethyl-β-carbolinium iodide. Cellular and Molecular Life Sciences. 29(5). 527–529. 4 indexed citations
7.
Ho, Beng T., Dorothy Taylor, K. E. Walker, & William M. McIsaac. (1973). The Mode of Action of 6-Methoxy-1,2,3,4-Tetrahydro-β-Carboline on Brain Serotonin. Canadian Journal of Biochemistry. 51(4). 482–485. 15 indexed citations
8.
Ho, Beng T., Dorothy Taylor, K. E. Walker, & William M. McIsaac. (1972). Metabolism of 6-Methoxytetrahydro-β-Carboline in Rats. Xenobiotica. 2(4). 349–362. 21 indexed citations
9.
McIsaac, William M., Dorothy Taylor, K. E. Walker, & B. T. HO. (1972). 6‐Methoxy‐1,2,3,4‐tetrahydro‐β‐carboline–α serotonin elevator1. Journal of Neurochemistry. 19(4). 1203–1206. 44 indexed citations
10.
Ho, Beng T., William M. McIsaac, Robert T. Harris, et al.. (1970). Biological activities of some 5-substituted N,N-dimethyltryptamines, ?-methyltryptamines, and gramines. Psychopharmacology. 16(5). 385–394. 17 indexed citations
11.
McIsaac, William M., et al.. (1970). Analogs of .alpha.-methylphenethylamine (amphetamine). I. Synthesis and pharmacological activity of some methoxy and/or methyl analogs. Journal of Medicinal Chemistry. 13(1). 26–30. 21 indexed citations
12.
Ho, Beng T., et al.. (1970). Inhibitors of Monoamine Oxidase VI: Effects of Substitution on Inhibitory Activity of 6(or 8)-Substituted β-Carbolines. Journal of Pharmaceutical Sciences. 59(10). 1445–1448. 14 indexed citations
13.
Ho, Beng T., et al.. (1969). Inhibitors of Monoamine Oxidase III: 9-Substituted-β-Carbolines. Journal of Pharmaceutical Sciences. 58(2). 219–221. 12 indexed citations
14.
Ho, Beng T., et al.. (1969). Inhibitors of Monoamine Oxidase V: Effect of Substitution on the Transport of Tetrahydro-β-Carboline Analogs to Mouse Brain. Journal of Pharmaceutical Sciences. 58(11). 1423–1425. 10 indexed citations
15.
Ho, Beng T., et al.. (1968). Inhibitors of Monoamine Oxidase. Journal of Pharmaceutical Sciences. 57(2). 269–274. 105 indexed citations
16.
Ho, Beng T., William M. McIsaac, & K. E. Walker. (1968). Inhibitors of Monoamine Oxidase II. Journal of Pharmaceutical Sciences. 57(8). 1364–1369. 15 indexed citations
17.
Ho, Beng T., et al.. (1967). Synthesis of 1-aryl(and 1-aralkyl)-β-carbolines. Canadian Journal of Chemistry. 45(23). 2963–2967. 9 indexed citations
18.
Charalampous, Kyriakos, et al.. (1966). Metabolic fate of mescaline in man. Psychopharmacology. 9(1). 48–63. 56 indexed citations
19.
Charalampous, Kyriakos, et al.. (1964). METABOLIC FATE OF BETA-(3,4,5-TRIMETHOXYPHENYL)-ETHYLAMINE (MESCALINE) IN HUMANS: ISOLATION AND IDENTIFICATION OF 3,4,5-TRIMETHOXYPHENYLACETIC ACID.. PubMed. 145. 242–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Talmage R. Bosin Breakdown of academic impact, for papers by H. Bruderer Breakdown of academic impact, for papers by Norihiko Tanno Breakdown of academic impact, for papers by Asher Kalir Breakdown of academic impact, for papers by Joseph T. Strupczewski Breakdown of academic impact, for papers by Maurice W. Gittos Breakdown of academic impact, for papers by Robert J. Borgman Breakdown of academic impact, for papers by Philip Abraham Breakdown of academic impact, for papers by David B. Rusterholz Breakdown of academic impact, for papers by Edward Macko
Rankless by CCL
2026